Primary mediastinal large B-cell lymphoma: A comparative study with nodular sclerosis-type Hodgkin's disease

International Journal of Hematology

Volumn 74, Issue 2, 2001, Pages 178-185

  Yonetani, Noboru ^a   Kurata, Masayuki ^a   Nishikori, Momoko ^a   Haga, Hironori ^a   Ohmori, Katsuyuki ^a   Yamabe, Hirohiko ^a   Uchiyama, Takashi ^a   Ohno, Hitoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biweekly CHOP; CD30; Nodular sclerosis type Hodgkin's disease; Primary mediastinal large B cell lymphoma; Reed Sternberg cell

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CD30 ANTIGEN; TUMOR ANTIGEN;

ADULT; ARTICLE; B CELL LYMPHOMA; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; LYMPH NODE; MALE; MEDIASTINUM TUMOR; MIDDLE AGED; PATHOLOGY; SCLEROSIS; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD20; ANTIGENS, CD30; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; SCLEROSIS; TREATMENT OUTCOME;

EID: 0035431467     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982002     Document Type: Article

References (25)

1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1991. J Clin Oncol. 1999;17: 3835-3849.
2. Lazzarino M, Orlandi E, Paulli M, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol. 1993;11:2306-2313.
3. Aisenberg AC. Primary large-cell lymphoma of the mediastinum. J Clin Oncol. 1993;11:2291-2294.
4. Aisenberg AC. Primary large cell lymphoma of the mediastinum. Semin Oncol. 1999;26:251-258.
5. Abou-Elella AA, Weisenburger DD, Vose JM, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol. 1999;17:784-790.
6. al-Sharabati M, Chittal S, Duga-Neulat I, et al. Primary anterior mediastinal B-cell lymphoma. A clinicopathologic and immunohistochemical study of 16 cases. Cancer. 1991;67:2579-2587.
7. Paulli M, Strater J, Gianelli U, et al. Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol. 1999;30:178-187.
8. Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol. 1999;112:241-247.
9. Chadburn A, Frizzera G. Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma. Am J Clin Pathol. 1999;112: 155-158.
10. Lavabre-Bertrand T, Donadio D, Fegueux N, et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer. 1992;69:2561-2566.
11. Trump DL, Mann RB. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer. 1982;50: 277-282.
12. Kirn D, Mauch P, Shaffer K, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993;11:1336-1343.
13. Jacobson JO, Aisenberg AC, Lamarre L, et al. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer. 1988;62: 1893-1898.
14. Kawabata Y, Hirokawa M, Horiuchi T, et al. Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma [in Japanese]. Rinsho Ketsueki. 1997; 38:674-681.
15. Sehn LH, Antin JH, Shulman LN, et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998;91:717-723.
16. Tanosaki R, Okamoto S, Akatsuka N, et al. Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma. Cancer. 1994;74: 1939-1944.
17. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985;102: 596-602.
18. Matsuura Y, Nakamura H, Kogure K, et al. A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas [in Japanese]. Gan To Kagaku Ryoho. 1994;21: 237-241.
19. Okamoto M, Maruyama F, Tsuzuki M, et al. Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin [in Japanese]. Rinsho Ketsueki. 1994;35: 635-641.
20. von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol. 1997;151:1123-1130.
21. Falini B, Venturi S, Martelli M, et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol. 1995;89:780-789.
22. Hofmann WJ, Momburg F, Moller P. Thymic medullary cells expressing B lymphocyte antigens. Hum Pathol. 1988;19: 1280-1287.
23. Isaacson PG, Norton AJ, Addis BJ. The human thymus contains a novel population of B lymphocytes. Lancet. 1987;2:1488-1491.
24. Lazzarino M, Orlandi E, Paulli M, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol. 1997;15: 1646-1653.
25. Martelli MP, Martelli M, Pescarmona E, et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol. 1998; 9:1027-1029.